Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/41065
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCan P.-Y.en
dc.contributor.authorHoldsworth S.R.en
dc.date.accessioned2021-05-14T14:03:43Zen
dc.date.available2021-05-14T14:03:43Zen
dc.date.copyright2015en
dc.date.created20160216en
dc.date.issued2016-02-16en
dc.identifier.citationClinical Journal of the American Society of Nephrology. 10 (12) (pp 2243-2254), 2015. Date of Publication: 07 Dec 2015.en
dc.identifier.issn1555-9041en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/41065en
dc.description.abstractCytokines play an important role in host defense against microorganisms. They orchestrate innate immunity by inducing protective local inflammation and systemic acute phase responses. Cytokines are important in initiating, amplifying, directing, mediating, and regulating adaptive immunity. Unfortunately, they may also direct tissue damage if excessive responses occur or if they are involved in directing and mediating autoimmunity. Under these circumstances, cytokines are potential therapeutic targets. Over the last 20 years, we have seen the successful development and clinical implementation of biologic strategies that target key cytokines in specific inflammatory diseases with efficacy, specificity, and toxicity profiles challenging conventional drug therapies. These therapies are finding new applications and many new agents show promise. Unfortunately, these new cytokine-based therapies have had little effect on renal disease. This review provides evidence that common renal diseases, including those causing AKI and the autoimmune proliferative and crescentic forms of GN, have cytokine mediation profiles that suggest they would be susceptible to cytokine-targeting therapeutic strategies.Copyright © 2015 by the American Society of Nephrology.en
dc.languageEnglishen
dc.languageenen
dc.publisherAmerican Society of Nephrology (E-mail: email@asn-online.org)en
dc.relation.ispartofClinical Journal of the American Society of Nephrologyen
dc.titleCytokines: Names and numbers you should care about.en
dc.typeReviewen
dc.type.studyortrialReview article (e.g. literature review, narrative review)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.2215/CJN.07590714en
dc.publisher.placeUnited Statesen
dc.identifier.source608295937en
dc.identifier.institution(Holdsworth, Can) Center for Inflammatory Diseases, Department of Medicine, Monash University, Clayton, VIC, Australia (Holdsworth) Department of Nephrology, Monash Health, Clayton, VIC, Australiaen
dc.description.addressS.R. Holdsworth, Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, 246 Clayton Road, Clayton, VIC 3168, Australia. E-mail: Stephen.holdsworth@monash.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2016 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailHoldsworth S.R.; Stephen.holdsworth@monash.eduen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeReview-
crisitem.author.deptImmunology and Allergy-
Appears in Collections:Articles
Show simple item record

Page view(s)

26
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.